The United States Patent and Trademark Office (USPTO) has granted patent US12582631B2 to Chinook Therapeutics, Inc. The patent covers "Methods of improving renal function" and was filed on August 16, 2022, with a grant date of March 24, 2026. The patent includes 36 claims and is classified under CPC codes A61K 31/41 and A61P 31/12.

This patent grant is a routine event for a specific company and does not impose new regulatory obligations on other entities. Compliance officers should note this as a development in the intellectual property landscape for therapeutics related to kidney function. No immediate actions are required for compliance purposes based on this patent grant.